• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, July 9, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

VTI signs distribution deal with Menicon

by Myles Hume
October 9, 2019
in Business, Company updates & acquisitions, International, Myopia, News
Reading Time: 2 mins read
A A
The lenses have demonstrated a treatment effect of 69% for refractive error and 59% for axial length vs. control group.

The lenses have demonstrated a treatment effect of 69% for refractive error and 59% for axial length vs. control group.

Share on FacebookShare on Twitter

ASX-listed Visioneering Technologies (VTI) has signed a sales and distribution deal with Japan’s largest contact lens company, mapping a path into the lucrative European market.

VTI, the US-based maker of the NaturalVue Multifocal contact lens for myopes and presbyopes, announced to investors last week it has entered into a definitive agreement with contact lens giant Menicon’s wholly-owned subsidiary NKL Contactlenzen, B.V.

In a deal aimed at the burgeoning paediatric myopia market, VTI will supply NaturalVue in Menicon-branded packaging for sale and distribution in Europe. The lenses will be packaged as Menicon Bloom Day Contact Lenses for Myopia Progression Control.

For Menicon, the announcement builds on the May launch of Menicon Bloom Night, the first orthokeratology product to receive clearance in Europe for treating pediatric myopia progression. The hyper oxygen-permeable rigid lens was the company’s first within the newly announced Menicon Bloom Myopia Control System.

The companies claim Menicon Bloom Day (NaturalVue) and Menicon Bloom Night, expected to be available in Australia early next year, are each suited for differing segments of the pediatric myopia market.

The agreement is the next step of VTI’s global expansion, with its daily disposable contact lenses having received marketing clearances for pediatric myopia control in the European Union, Australia, and New Zealand, and most recently a Certificate of Listing in Hong Kong.

“Menicon is a well-respected global leader in the contact lens industry, and a company dedicated to the fight against the myopia epidemic,” Dr Stephen Snowdy, VTI CEO, said.

“Menicon’s willingness to make NaturalVue such a significant part of its new Bloom Myopia Control Management System is further validation of NaturalVue daily disposable contact lenses. Partnering with Menicon will help us expand the availability of NaturalVue MF in Europe and potentially other international markets.”

The terms of the deal do not prohibit VTI from marketing, selling, or distributing NaturalVue in Europe under VTI’s own or others’ brand names. The agreement is cancellable with one year’s notice, although not before the second anniversary of the agreement.

Additionally, in the December quarter VTI expects to receive US$475,000 in cash related to an initial stocking order under the agreement, and to book the cash as revenue in the December 2019 or March 2020 quarter, when the initial stocking lenses are delivered to NKL. The delivery of the initial stocking lenses is dependent on certain regulatory review and approvals.

Tags: MeniconNaturalVueVTI

Related Posts

Eyecare practitioners taking parental leave can now get relief from part of their fee to Ahpra. Image: Prostock-studio/stock.adobe.com.

Ahpra announces fee relief for practitioners on parental leave

by Staff Writer
July 9, 2025

Practitioners taking parental leave can have money back in their pockets, as Australian Health Practitioner Regulation Agency's (Ahpra) parental leave...

Image: Andrii Yalanskyi/Shutterstock.com.

People on the move – July 2025

by Staff Writer
July 9, 2025

Welcome to People on the move – July 2025, Insight’s monthly bulletin to keep the Australian ophthalmic sector updated on new appointments...

A holistic approach extends care beyond the clinical setting, and considers mental wellbeing, access to assistive technology, communication needs, and quality-of-life, SeeWay says. Image: Ievgen Skrypko/stock.adobe.com.

Beyond the diagnosis: Why holistic eye health matters more than ever

by Myles Hume
July 8, 2025

When people dealing with vision loss are supported to learn how to adapt, and feel emotionally supported, their outcomes improve...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited